Privacy Analytics Inc., a Toronto, CA-based company that is developing a software platform to help organizations such as health centers disclose detailed disease and treatment data without compromising individual privacy, has received an an equity investment from The Ontario Institute for Cancer Research (OICR).
The software platform, called Privacy Analytics Risk Assessment Tool (PARAT), is currently being used by hospitals and patient registries in Canada. The funding (of undisclosed amount) from OICR will be used to extend the functionality of PARAT to include more powerful capabilities, as well as to support the marketing and sales of the improved product into new markets.
The platform is a Windows based application. It is compatible with a number of databases (Oracle, Microsoft SQL Server).
Funding is provided through its Intellectual Property Development and Commercialization Program, which provides seed funding for late stage academic projects that meet specific market-oriented criteria.